Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Australia's Kai Ellice-Flint has won the men's longboard title in El Salvador, beating top seed Edouard Delpero in the decider. Ellice-Flint won the title on a surfboard that he shaped himself. His ...

“I have used it on gravel parking lots, sand, rainwater, and grass.” A Hoteel 1200-Watt Electric Longboard is just $330 at Walmart right now, 53% off its normal $700 price tag. The blue model is ...

In this video, we demonstrate how to create a DIY longboard using various tools and materials. The project includes: - Titebond 3 glue - Spray adhesive - Jig saw - Roundover bit - Double sided tape - ...

Longboarding has had to struggle for its moment in the sun since its richer cousin of shortboarding was incepted back in the late ‘60s. The first men’s Longboard World Champion was crowned in 1987 and ...

Like bees heading towards the hive, at the beginning of each April, surfers from all over the world make their way from their corners of the globe to The Single Fin Mingle in Sumner, New Zealand, a ...

In a significant corporate development, Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) has finalized its acquisition by H. Lundbeck A/S, a Danish pharmaceutical firm, as of Monday. This transaction ...

Lundbeck will buy Longboard Pharmaceuticals and its 5-HT 2C receptor agonist bexicaserin, which is currently in phase III development for seizures associated with Dravet syndrome. The deal, valued at ...

Two Southern California surfers have claimed the 2024 World Surf League’s World Longboard Championship – a second win for Dana Point native Rachael Tilly and a fourth for San Diego’s Taylor Jensen.

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion, driven by the potential of bexicaserin. Bexicaserin shows promising seizure reduction data, ...

Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...